₹260.05
▲ +3.44 +1.34%
As of 28 Jul 2026 · delayed
BSE Listed
ESM 1Aptus Pharma Limited (544529)
Volume: 13,600Avg Vol 1W: 8,720Avg Vol 1M: 14,67352W Range:₹32.32₹264
Key Ratios
Checked 2h agoMarket Cap—
Current Price₹260.05
Previous Close₹256.61
High / Low (52w)₹264 / ₹32.32
Volume13,600
Avg Vol (1W)8,720
Avg Vol (1M)14,673
Stock P/E—
Book Value—
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B—
Debt / Equity1.79
50 DMA₹221.54
200 DMA—
Day change+1.34%
SurveillanceESM 1
Price Chart
₹260.05▲ 666.21% · 1Y
2025-09-302026-07-28
20-day avg volume: 15K shares
Pros
- Company is almost debt-free.
- Revenue grew 38% YoY.
- Net profit is growing year over year.
Profit & Loss (Annual)
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Revenue | ₹14 Cr | ₹18 Cr | ₹25 Cr |
| EBITDA | ₹0 Cr | ₹1 Cr | ₹5 Cr |
| Net Profit | ₹0 Cr | ₹1 Cr | ₹3 Cr |
| EPS | 1.3 | 5.32 | 6.37 |
Balance Sheet
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Total Assets | ₹6 Cr | ₹10 Cr | ₹22 Cr |
| Total Liabilities | ₹5 Cr | ₹8 Cr | ₹15 Cr |
| Equity | ₹1 Cr | ₹2 Cr | ₹7 Cr |
| Total Debt | — | — | — |
Cash Flow
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Operating | ₹0 Cr | ₹-2 Cr | ₹-1 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹-1 Cr |
| Financing | ₹1 Cr | ₹3 Cr | ₹7 Cr |
| Free Cash Flow | ₹0 Cr | ₹-2 Cr | ₹-1 Cr |
Shareholding
Promoter 72.89% Institutions 0% Public 27.11%
Efficiency & Working Capital
ROCE—
Interest Coverage9.9
Dividend Payout—
Debtor Days84 d
Inventory Days105 d
Payable Days19 d
Cash Conversion Cycle169 d
Working Capital Days189 d
Shareholding Details
As of 2026-06-30
Promoter72.9%
FII0%
DII0%
Institutions0%
Public27.1%
Promoter Pledge0%
No. of Shareholders686
Shareholding Pattern
Quarterly — figures in %. Latest 6 quarters.
| Period | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | May 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 72.9% | 72.9% | 72.9% | 72.9% | 72.9% | 72.9% |
| FIIs | 10% | 10% | 0% | 0% | 0% | 0% |
| DIIs | 2.8% | 2.8% | 0% | 0% | 0% | 0% |
| Public | 14.3% | 14.3% | 27.1% | 27.1% | 27.1% | 27.1% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 213 | 213 | 302 | 337 | 356 | 686 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Tejash Maheshchandra Hathi | Shareholding of Promoter and Promoter Group | 11.4% | 19,62,500 |
| Kapil Hasmukhbhai Chandarana | Shareholding of Promoter and Promoter Group | 11.4% | 19,62,500 |
| Riddhish Natwarlal Tanna | Shareholding of Promoter and Promoter Group | 8.6% | 14,82,500 |
| Kripaliben Mayank Thakker | Shareholding of Promoter and Promoter Group | 8.6% | 14,82,500 |
| Milly Chetan Lalseta | Shareholding of Promoter and Promoter Group | 8.6% | 14,82,500 |
| Kunjal Piyushbhai Unadkat | Shareholding of Promoter and Promoter Group | 8.6% | 14,82,500 |
| Gaurang Rameshchandra Thakker | Shareholding of Promoter and Promoter Group | 8.6% | 14,82,500 |
| Ghanshyam Vinubhai Pansuriya | Shareholding of Promoter and Promoter Group | 5.3% | 9,10,000 |
| Chatrabhuj Vallabhbhai Butani | Shareholding of Promoter and Promoter Group | 1.5% | 2,52,500 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Tejash Maheshchandra Hathi | Managing Director | 2025 |
| CHETAN SHANTILAL LALSETA | Non Executive Director | 2025 |
| Jyotiben Hasmukhbhai Chandarana | Non Executive Director | 2025 |
| Riddhish Natwarlal Tanna | Non Executive Director | 2025 |
| Vikas Rambhai Jobanputra | Independent Director | 2025 |
| Sejal Harit Palan | Independent Director | 2025 |
| Mohini Hardikbhai Gandhi | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 5 | 5 | 5 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| bonus | 2026-05-12 | Bonus issue 3:2 | — |
| bonus | 2026-05-12 | 3:2 | 3:2 Bonus Issue of Equity Shares |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 0 | 1 | 2 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 1 | 1 |
Insider / Designated-Person Trades
9 recent disclosure(s)
Chatrabhujbhai ButaniDisposal · 1,24,000
TEJASH MAHESHCHANDRA HATHIAcquisition · 10,000
Riddhish Natwarlal TannaAcquisition · 18,000
Milly Chetan LalsetaAcquisition · 18,000
Kunjal Piyushbhai UnadkatAcquisition · 18,000
Kripaliben Mayank ThakkerAcquisition · 18,000
Substantial Acquisitions (SAST)
9 disclosure(s)
Off Market11/05/2026 · 10,000
Off Market / Inter se transfer11/05/2026 · 18,000
Off Market / Inter se transfer11/05/2026 · 18,000
Off Market / Inter se transfer11/05/2026 · 18,000
Off Market / Inter se transfer11/05/2026 · 18,000
Off Market11/05/2026 · 10,000
Company Information
🌐 www.aptus-pharma.com ↗
📍 Ashutosh Buildcon Asali, Daskroi, Ahmedabad, Gujarat, 382427
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Sampat Aluminium LimitedIvalue InfosolutionsJD Cables LimitedSaatvik Green EnergyAtlanta ElectricalsGanesh Consumer ProductsAnand Rathi Share & Stock BrokersTrue Colors LimitedSolarworld Energy SolutionsSeshaasai TechnologiesJaro Inst of Tech Mgmt & ResearchBharatRohan Airborne Innovations Ltd.All “54” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search